One study found elevated levels of soluble MICA (sMICA, 21 ng/mL) in the serum of nearly all PCa patients with a Gleason score ≥ 6, suggesting that sMICA could serve as a novel biomarker for PCa [74]. Here, MICA is linked to posterior cortical atrophy.